Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Rehavi

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Brain Research|February 20, 2003
Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depressionKarin Schwartz, Gal Yadid, Abraham Weizman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2003
Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophreniaLee Zuckerman, Moshe Rehavi, Rachel Nachman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 20, 2002
Increased platelet vesicular monoamine transporter density in adult schizophrenia patientsMichal Zucker, Avi Valevski, Abraham Weizman, et al.
Pharmacogenomics|March 19, 2010
Human lymphoblastoid cell line panels: novel tools for assessing shared drug pathwaysAyelet Morag, Julia Kirchheiner, Moshe Rehavi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 23, 2008
Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidolAdi Malkoff, Abraham Weizman, Illana Gozes, et al.
Life Sciences|September 7, 2002
Inhibition of vesicular uptake of monoamines by hyperforinNetta Roz, Yehuda Mazur, Amiram Hirshfeld, et al.
Brain Research|December 24, 2008
Neuroprotection by rasagiline in thiamine deficient ratsSarah Eliash, Vered Dror, Sasson Cohen, et al.
Biochemical Pharmacology|August 11, 2010
N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitorYona Bismuth-Evenzal, Netta Roz, David Gurwitz, et al.
Brain Research|February 15, 2014
Rasagiline prevents neurodegeneration in thiamine deficient rats-a longitudinal MRI studyVered Dror, Moshe Rehavi, Inbal E Biton, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 2, 2004
Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytesTal Barkan, David Gurwitz, Galit Levy, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Brain Research|February 20, 2003
Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depressionKarin Schwartz, Gal Yadid, Abraham Weizman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2003
Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophreniaLee Zuckerman, Moshe Rehavi, Rachel Nachman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 20, 2002
Increased platelet vesicular monoamine transporter density in adult schizophrenia patientsMichal Zucker, Avi Valevski, Abraham Weizman, et al.
Pharmacogenomics|March 19, 2010
Human lymphoblastoid cell line panels: novel tools for assessing shared drug pathwaysAyelet Morag, Julia Kirchheiner, Moshe Rehavi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 23, 2008
Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidolAdi Malkoff, Abraham Weizman, Illana Gozes, et al.
Life Sciences|September 7, 2002
Inhibition of vesicular uptake of monoamines by hyperforinNetta Roz, Yehuda Mazur, Amiram Hirshfeld, et al.
Brain Research|December 24, 2008
Neuroprotection by rasagiline in thiamine deficient ratsSarah Eliash, Vered Dror, Sasson Cohen, et al.
Biochemical Pharmacology|August 11, 2010
N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitorYona Bismuth-Evenzal, Netta Roz, David Gurwitz, et al.
Brain Research|February 15, 2014
Rasagiline prevents neurodegeneration in thiamine deficient rats-a longitudinal MRI studyVered Dror, Moshe Rehavi, Inbal E Biton, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 2, 2004
Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytesTal Barkan, David Gurwitz, Galit Levy, et al.
Pageof 5